Unexpectedly High Frequency of Antibody to Mycoplasma pneumoniae in Human Sera as Measured by Sensitive Technique, H Brunner, B Prescott, H Greenberg, WD James, R Horswood, RM Channock, J Infect Dis, 1977; 135, 524.

Cell Wall Deficient Forms: Stealth Pathogens, 2nd ed., LH Mattman, CRC Press, Cleveland, 1974.

Miscellaneous

Tetracyclines: nonantibiotic properties and their clinical implications.. Sapadin AN, Fleischmajer R., Am Acad Dermatol. 2006 Feb;54(2):258-65.The therapeutic effects of tetracycline and its analogues in various diseases have also been investigated. These include autoimmune disorders such as rheumatoid arthritis and scleroderma. Department of Dermatology, Mount Sinai School of Medicine, New York.

Etiologic diagnosis of 204 pericardial effusions. Levy PY, Corey R, Berger P, Habib G, Bonnet JL, Levy S, Messana T, Djiane P, Frances Y, Botta C, DeMicco P, Dumon H, Mundler O, Chomel JJ, Raoult D. Medicine (Baltimore). 2003 Nov;82(6):385-91

Do Minocycline and Other Tetrayclines Have a Place in Rheumatology? E Tousirot, J Despaux, D Wendling, Rev Rheum Engl Ed, 1997; 64:7-9, 474-480.

Tetracycline Prevents Cancellous Bone Loss and Maintains Near-Normal Rates of Bone Formation in Streptozotocin Diabetic Rats, S Bain, NS Ramamurthy, T Impeduglia, S Scolman, LM Golub, C Rubin, Bone, 1997; Aug. 21:2, 147-153.

Penetration and Bactericidal Activity of Cefixime in Synovial Fluid, E Somekh, L Heifetz, M Dan, F Poch, H Hafeli, A Tanai, Antimicrob Agents & Chemother, AMS, 1996; 40:5, 1198-1200.

The End of Self, S Richardson, Discover, April 1996, 80-87.

Antibiotic Susceptibilities of AIDS-Associated Mycoplasmas, SA Poulin, RE Perkins, RB Knudsin, J Clin Microbiol, 1994; 32:4, 1101-1103.

Second International Symposium on the Immunotherapy of the Rheumatic Diseases: Concepts and Overview, Clin & Exper Rheum II, 1993; (Supl 8), S1-S3.

Tetrayclines, Chloramphenicol, Erythromycin, Clindamycin, and Metronidazole, JD Smilack, WR Wilson, FR Cockerill, III, Mayo Clin Proc, 1991; 66, 1270-1l280.

In Vitro Susceptibilities of Mycoplasmas and Urealplasmas to New Macrolides and Aryl-Fluoroquinolones, KB Waites, GH Cassell, KC Canupp, PB Fernandes, Antimicrob Agents & Chemother, 1988; 32:10, 1500-1502.